AlphaCentric Advisors LLC - Q2 2021 holdings

$368 Million is the total value of AlphaCentric Advisors LLC's 211 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .

 Value Shares↓ Weighting
INVH  INVITATION HOMES INC$31,851,000
+16.6%
854,1440.0%8.65%
-6.1%
AMH  AMERICAN HOMES 4 RENTcl a$31,349,000
+16.5%
806,9240.0%8.51%
-6.2%
STXS  STEREOTAXIS INC$3,133,000
+43.5%
325,0000.0%0.85%
+15.6%
ISRG  INTUITIVE SURGICAL INC$1,839,000
+24.4%
2,0000.0%0.50%
+0.2%
OMCL  OMNICELL COM$1,515,000
+16.6%
10,0000.0%0.41%
-6.2%
AME  AMETEK INC$1,335,000
+4.5%
10,0000.0%0.36%
-15.8%
VIRX  VIRACTA THERAPEUTICS INC$1,048,000
+22.6%
92,4020.0%0.28%
-1.0%
CYBE  CYBEROPTICS CORP$1,024,000
+57.8%
25,0000.0%0.28%
+26.9%
NOVT  NOVANTA INC$1,011,000
+2.2%
7,5000.0%0.28%
-17.7%
CLPT  CLEARPOINT NEURO INC$955,000
-9.6%
50,0000.0%0.26%
-27.2%
CLDX  CELLDEX THERAPEUTICS INC NEW$836,000
+62.3%
25,0000.0%0.23%
+30.5%
GILD  GILEAD SCIENCES INC$813,000
+6.6%
11,8000.0%0.22%
-14.0%
 MICROBOT MED INC$794,000
-6.7%
100,0000.0%0.22%
-24.7%
BTAI  BIOXCEL THERAPEUTICS INC$727,000
-32.6%
25,0000.0%0.20%
-45.9%
BMRN  BIOMARIN PHARMACEUTICAL INC$668,000
+10.6%
8,0000.0%0.18%
-11.3%
MORF  MORPHIC HLDG INC$316,000
-9.2%
5,5000.0%0.09%
-26.5%
COLL  COLLEGIUM PHARMACEUTICAL INC$213,0000.0%9,0000.0%0.06%
-19.4%
ATHA  ATHIRA PHARMA INC$210,000
-44.4%
20,5380.0%0.06%
-55.1%
RVNC  REVANCE THERAPEUTICS INC$193,000
+6.0%
6,5000.0%0.05%
-14.8%
BIIB  BIOGEN INC$139,000
+24.1%
4000.0%0.04%0.0%
APLS  APELLIS PHARMACEUTICALS INC$126,000
+46.5%
2,0000.0%0.03%
+17.2%
ALLK  ALLAKOS INC$120,000
-25.5%
1,4000.0%0.03%
-38.9%
UTHR  UNITED THERAPEUTICS CORP DEL$99,000
+7.6%
5500.0%0.03%
-12.9%
HZNP  HORIZON THERAPEUTICS PUB L$94,000
+2.2%
1,0000.0%0.03%
-16.1%
ABBV  ABBVIE INC$48,000
+4.3%
4250.0%0.01%
-18.8%
BMY  BRISTOL-MYERS SQUIBB CO$47,000
+4.4%
7100.0%0.01%
-13.3%
TAK  TAKEDA PHARMACEUTICAL CO LTDsponsored ads$37,000
-7.5%
2,2000.0%0.01%
-23.1%
BFK  BLACKROCK MUN INCOME TRsh ben int$29,0000.0%1,9000.0%0.01%
-20.0%
BTA  BLACKROCK LONG-TERM MUN ADVA$24,000
+9.1%
1,7500.0%0.01%0.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-03-09
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HORIZON THERAPEUTICS PUB L12Q3 20232.9%
INTUITIVE SURGICAL INC12Q3 20231.3%
STEREOTAXIS INC12Q3 20231.0%
ALLIED MOTION TECHNOLOGIES I12Q3 20231.3%
AEROVIRONMENT INC12Q3 20231.3%
OMNICELL COM12Q3 20230.9%
ACCURAY INC12Q3 20230.8%
COLLEGIUM PHARMACEUTICAL INC12Q3 20231.1%
MICROBOT MED INC12Q3 20230.5%
ISHARES TR11Q3 202313.1%

View AlphaCentric Advisors LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-24
13F-HR2024-02-14
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-12
13F-HR/A2023-02-13
13F-HR2023-02-07
13F-HR2022-11-08
13F-HR2022-03-11
13F-HR2022-03-11

View AlphaCentric Advisors LLC's complete filings history.

Export AlphaCentric Advisors LLC's holdings